Skip to main content
Clinical and Translational Science logoLink to Clinical and Translational Science
. 2024 Apr 1;17(4):e13783. doi: 10.1111/cts.13783

Correction to “Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects”

PMCID: PMC10985217  PMID: 38561923

Park MY, Bae S, Heo JA, et al. Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects. Clin. Transl. Sci. 2023;16(7):1163–1176. doi: 10.1111/cts.13518. Epub 2023 Apr 24. PMID: 37095713; PMCID: PMC10339703.

The authors are adding the following information to the title page:

“Min Young Park and Sungyeun Bae contributed equally to this work.”

These authors made significant joint contributions to the work and should be acknowledged equally.


Articles from Clinical and Translational Science are provided here courtesy of Wiley

RESOURCES